Two challenges providers may face under the proposed rule.
While the jury is still out on how consumers will react to the administration’s proposed price transparency rule, there are two clear challenges that the ruling could pose for providers, according to one expert.
Under the proposed rule, hospitals would be more transparent about their charges.
“First, the proposed rule might significantly affect providers’ ability to negotiate varied rates in payer contracts,” says John Kelly, principal business advisor, Edifecs, a global health information technology solutions company based in Bellevue, Washington, with operations internationally. “Providers often do not want payers knowing the various rates they are charging and the discounts that some payers might be receiving.”
Second, this rule would require providers to publish a price list, he says.
Related: To Lower Healthcare Costs, Lower ED Visits
“However, in fee-for-service models, providers need to charge according to the chargemaster fee schedule,” Kelly says. “The reality is, hospital chargemasters are often far out of sync with the payments made under contracts to payers. Calculating a single price list that reflect reality will be a significant challenge. Patients rarely are charged the chargemaster price, so publishing the official chargemaster would be misleading and create a very negative view of a hospitals actual pricing practices.”
According to Kelly, as healthcare executives consider responding to this proposed rule, one solution might be to consider charging based on an average price of a service rather than the chargemaster price.
“Regardless, there is a clear movement toward greater cost transparency for patients, the key will be how we provide patients with the most current and accurate information rather than outdated models,” he says.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More